Cite Filings / MEDP / 0001193125-24-063698
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Medpace Holdings, Inc. · Filed 2024-03-08 · Acc 0001193125-24-063698

Documents 1

  • SC 13D/A Beneficial Ownership Report , d764000dsc13da.htm

Around this filing

  • 2024-03-08 4 CEO sold 200,000 shares at an average $411.61 ($82,321,250)
  • 2024-03-08 4 10% owner sold 200,000 shares at an average $411.61 ($82,321,250)
  • 2024-03-08 4 Director sold 472 shares at $415.00 ($195,880)
  • 2024-03-08 SC 13D/A Beneficial Ownership Report
  • 2024-03-07 144 Sale of Securities
  • 2024-03-07 144 Sale of Securities
  • 2024-02-28 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.1%
  2. 2026-11-13 SCHEDULE 13G · AQR Capital Management, LLC 5.00%
Loading d764000dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…